Real-time enrollment status for this metastatic hr+/her2- breast cancer clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 7:19 AM UTC
| NCT Number | NCT07426822 |
| Recruiting Status | Recruiting |
| Condition | Metastatic HR+/HER2- Breast Cancer |
| Phase | PHASE2 |
| Target Enrollment | 108 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Maryam Lustberg |
| Last Updated on CT.gov | July 29, 2026 (Jul 29, 2026) |
As of September 1, 2026: Clinical trial NCT07426822 is currently recruiting participants. This phase2 study for metastatic hr+/her2- breast cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Maryam Lustberg. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07426822 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07426822 was last updated Jul 29, 2026 (July 29, 2026). HelloStudys verifies this status automatically.